Jean Zhao

24PUBLICATIONS
222CO-AUTHORS
Molecular targetsProteomics and intermolecular interactions (excl. medical proteomics)Predictive and prognostic markersHaematological tumoursGlycobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 19, 2026
Paxalisib with Trastuzumab for HER2-Positive Metastatic Breast Cancer with Active Brain Metastases: A Phase II Trial with Integrated Plasma and CSF ctDNA Analyses.

|Sep 30, 2026
PI(3,5)P2 controls the signaling activity of class I PI3K.

|May 20, 2026
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer.

|May 04, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

|Feb 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

Xin Cheng, Changli Qian, Erica Holdridge

|Feb 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolution.

Sebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler

Pageof 4

Frequent Collaborators

6 joint publications

Johann S Bergholz

5 joint publications

Sheheryar Kabraji

3 joint publications

Hao Gu

3 joint publications

Thomas M Roberts